Initial Management of Costochondritis
The first-line treatment for costochondritis is nonsteroidal anti-inflammatory drugs (NSAIDs) at the maximum tolerated and approved dosage for 1-2 weeks to reduce inflammation and pain. 1
Diagnosis and Clinical Presentation
Costochondritis is characterized by:
- Tenderness of costochondral joints 2
- Localized chest pain that may be reproduced by palpation 3
- Absence of swelling, redness, or warmth (distinguishing it from Tietze syndrome)
Key Physical Examination Findings
- Reproducible pain on palpation of the affected costochondral junctions
- Normal vital signs
- Absence of other concerning findings that might suggest cardiac, pulmonary, or other serious causes
Differential Diagnosis
It's important to rule out more serious causes of chest pain, including:
- Acute coronary syndrome
- Pulmonary embolism
- Aortic dissection
- Pneumothorax
- Pericarditis
- Pneumonia 2
Treatment Algorithm
Pharmacological Management
First-line therapy: NSAIDs at maximum tolerated dosage for 1-2 weeks 1
- Options include:
- Ibuprofen (up to 1800 mg/day)
- Naproxen (375-1100 mg/day)
- Diclofenac (150 mg/day)
- Celecoxib (200-400 mg/day)
- Options include:
Alternative pharmacological options:
Non-Pharmacological Management
Local heat or cold application:
- Heat: Heating pad for 15-20 minutes several times daily
- Cold: Ice wrapped in a towel for 10-minute periods 1
Activity modification:
- Relative rest
- Avoid activities that exacerbate pain
- Avoid muscle overuse of the chest wall 1
Stretching exercises:
- Studies have shown progressive significant improvement in patients treated with stretching exercises compared to control groups 4
- Consider referral to physical therapy for specific stretching regimens
Follow-up and Treatment Monitoring
- Evaluate treatment response after 2-4 weeks 1
- If symptoms persist beyond 4-6 weeks despite appropriate treatment, consider further evaluation to rule out other causes 1
- For persistent cases (atypical costochondritis), consider referral to physical medicine and rehabilitation for manipulative therapy and soft tissue mobilization 5
Special Considerations
- Be cautious with NSAID use in patients with gastrointestinal, renal, or cardiovascular risk factors 1
- In patients older than 35 years or those with risk factors for coronary artery disease, obtain an ECG to rule out cardiac causes 3
- Distinguish between non-infectious costochondritis (more common) and infectious costochondritis (rare, requires different management including antibiotics and possible surgical debridement) 6, 7
Treatment Pitfalls to Avoid
- Long-term use of NSAIDs due to potential adverse effects 1
- Failure to rule out serious causes of chest pain before diagnosing costochondritis
- Inadequate follow-up for persistent symptoms
- Overlooking the potential benefit of physical therapy interventions for persistent cases
Most cases of costochondritis are self-limiting and resolve with conservative management within a few weeks to months, but proper initial management can significantly improve patient comfort and outcomes.